Sensible Financial Planning & Management LLC. Trims Stock Holdings in Cabot Co. (NYSE:CBT)

Sensible Financial Planning & Management LLC. trimmed its holdings in Cabot Co. (NYSE:CBTFree Report) by 4.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 31,540 shares of the specialty chemicals company’s stock after selling 1,520 shares during the quarter. Cabot makes up about 0.6% of Sensible Financial Planning & Management LLC.’s portfolio, making the stock its 22nd biggest position. Sensible Financial Planning & Management LLC.’s holdings in Cabot were worth $2,634,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of CBT. Arlington Trust Co LLC purchased a new position in Cabot during the 4th quarter worth $34,000. GAMMA Investing LLC purchased a new position in Cabot during the 4th quarter worth $44,000. Milestone Investment Advisors LLC purchased a new position in Cabot during the 3rd quarter worth $79,000. NBC Securities Inc. purchased a new position in Cabot during the 3rd quarter worth $162,000. Finally, Blue Trust Inc. increased its holdings in Cabot by 33.4% during the 4th quarter. Blue Trust Inc. now owns 2,527 shares of the specialty chemicals company’s stock worth $211,000 after purchasing an additional 632 shares during the period. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have commented on CBT shares. StockNews.com downgraded Cabot from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 14th. UBS Group cut Cabot from a “buy” rating to a “neutral” rating and dropped their target price for the company from $90.00 to $87.00 in a research report on Monday, January 8th. Deutsche Bank Aktiengesellschaft cut Cabot from a “buy” rating to a “hold” rating and increased their target price for the company from $88.00 to $95.00 in a research report on Thursday, April 18th. Finally, Mizuho started coverage on Cabot in a research report on Wednesday, March 27th. They set a “buy” rating and a $104.00 target price on the stock. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $90.17.

Read Our Latest Stock Report on CBT

Cabot Stock Up 0.0 %

Shares of Cabot stock traded up $0.04 during trading on Wednesday, reaching $93.42. The company’s stock had a trading volume of 178,621 shares, compared to its average volume of 304,681. The company has a quick ratio of 1.30, a current ratio of 2.04 and a debt-to-equity ratio of 0.74. The company has a market cap of $5.18 billion, a price-to-earnings ratio of 12.13, a P/E/G ratio of 0.98 and a beta of 1.28. Cabot Co. has a 1-year low of $63.73 and a 1-year high of $98.34. The company has a 50-day simple moving average of $88.80 and a two-hundred day simple moving average of $80.17.

Cabot (NYSE:CBTGet Free Report) last posted its quarterly earnings data on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. The firm had revenue of $958.00 million during the quarter, compared to analysts’ expectations of $927.28 million. Cabot had a return on equity of 25.52% and a net margin of 11.24%. As a group, equities analysts forecast that Cabot Co. will post 6.58 earnings per share for the current year.

Insider Transactions at Cabot

In related news, EVP Jeff Ji Zhu sold 55,233 shares of the firm’s stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $79.91, for a total value of $4,413,669.03. Following the completion of the transaction, the executive vice president now owns 97,201 shares in the company, valued at approximately $7,767,331.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 3.07% of the company’s stock.

Cabot Company Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Further Reading

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.